Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8957
Feasibility Trial of Postoperative Radiotherapy + Cisplatin Followed by Three Courses of 5-FU + Cisplatin in Patients with Resected Head and Neck Cancer
Research Committee(s)
Head and Neck Cancer
Activated
05-01-1990
Closed
05-01-1992
Closed
Phase
SWOG Clinical Trial Number
SWOG-8947
Central Lymphoma Serum Repository Protocol
Research Committee(s)
Lymphoma
Activated
04-15-1990
Closed
Phase
Accrual
23%
SWOG Clinical Trial Number
SWOG-8939
Evaluation of Merbarone in Colorectal Cancer
Activated
04-15-1990
Closed
07-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8929
Evaluation of Merbarone in Patients with Advanced Renal Cell Carcinoma
Activated
04-15-1990
Closed
08-01-1992
Closed
Phase
Accrual
74%
SWOG Clinical Trial Number
SWOG-8954
Evaluation of the L-17M Protocol in the Management of Patients with Lymphoblastic Lymphoma
Research Committee(s)
Lymphoma
Activated
04-15-1990
Closed
05-15-1997
Closed
Phase
SWOG Clinical Trial Number
SWOG-8859 (INT-0110)
DNA Flow Cytometric Analysis in Patients with Prostate Cancer: A Companion Protocol to SWOG-8890 (INT-0109)
Activated
04-15-1990
Closed
01-01-1992
Closed
Phase
Accrual
70%
Published
SWOG Clinical Trial Number
SWOG-8902
Phase I Trial of Doxorubicin plus Carboplatin with GM-CSF in Patients with Advanced, Previously Treated Cancer
Activated
04-15-1990
Closed
05-01-1992
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-9011
High Dose Etoposide, Cyclophosphamide and Either Fractionated Total Body Irradiation or Carmustine Combined with Autologous Bone Marrow Rescue for Refractory or Relapsed Hodgkin's Disease
Research Committee(s)
Lymphoma
Activated
04-15-1990
Closed
12-01-1995
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
SWOG-8890 (INT-0109)
Radical Prostatectomy versus Radiation Therapy for Clinical Stage A2 and B Adenocarcinoma of the Prostate (N0,M0)
Activated
04-01-1990
Closed
01-01-1992
Closed
Phase
Accrual
80%
Published
SWOG Clinical Trial Number
SWOG-8932
Evaluation of Piroxantrone in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Activated
04-01-1990
Closed
07-15-2009
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-8916
Evaluation of Merbarone in Pancreatic Adenocarcinoma
Activated
03-15-1990
Closed
06-15-1991
Closed
Phase
Accrual
48%
Published
SWOG Clinical Trial Number
SWOG-8944
A Study of Carboplatin (CBDCA) in Refractory Multiple Myeloma
Activated
03-01-1990
Closed
06-01-1991
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
SWOG-8866
Evaluation of Piroxantrone in Advanced and Metastatic (Stage IV) Non-Small Cell Lung Cancer
Activated
03-01-1990
Closed
05-01-1991
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8915
Study of 6-Thioguanine Administered as 120 Hour Continuous Infusion for Refractory or Recurrent Small Cell Lung Carcinoma
Activated
03-01-1990
Closed
12-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8940
A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer
Activated
03-01-1990
Closed
11-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8942
High Dose Etoposide, Cyclophosphamide and Either Fractionated Total Body Irradiation or Carmustine Combined with Autologous Bone Marrow Rescue for Refractory or Relapsed Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
03-01-1990
Closed
12-15-1994
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
SWOG-8923
Neo-FAC for Poor Prognosis Stage IV Breast Cancer, A Phase II Pilot Study
Research Committee(s)
Breast Cancer
Activated
02-15-1990
Closed
06-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8921
Trials of Cyclophosphamide, IL-2, DTIC/IL-2, and DTIC/Cisplatin/Tamoxifen in Stage IV Melanoma
Research Committee(s)
Melanoma
Activated
02-15-1990
Closed
09-01-1991
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8994 (EST-C-0690) (INT-0086)
Evaluation of Quality of Life in Patients with Stage C Adenocarcinoma of the Prostate Enrolled on SWOG-8794 (INT-0086)
Activated
02-15-1990
Closed
01-01-1997
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8906
Evaluation of Merbarone in Hepatoma, Phase II
Activated
02-01-1990
Closed
05-01-1992